Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.
about
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesProtective and detrimental roles for regulatory T cells in a viral model for multiple sclerosisEngineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces.HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patientsTumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.Following up tumor-specific regulatory T cells in cancer patients.Natural and induced T regulatory cells in cancer.Immunobiology of TNFSF15 and TNFRSF25.Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.Ontogeny of Tumor-associated CD4+CD25+Foxp3+ T-regulatory Cells.Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancerTrial watch: Dendritic cell-based interventions for cancer therapy.Trial Watch: Toll-like receptor agonists for cancer therapy.Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma.
P2860
Q26798402-6A6CB608-9B81-4FDB-B066-DCF74D318B8BQ33901171-64DB8B10-336F-4104-BAF1-8AC840D3D066Q35998238-AC9CB4CD-7D91-4FD1-B77A-1B01D63FA7EBQ37028039-A183CD06-439F-4E38-8309-E004EA549ACAQ37028767-4F127791-82B2-45CC-9BAD-94249D23EC50Q37195258-ACF75E28-598A-48D1-9697-4767F532258BQ38123165-D05F790E-CE06-41B7-AEDE-4B010E8ED077Q38163429-D3767C4D-65DF-4CDC-A7BB-809E5A8B2743Q38164258-A2EC2061-3E7C-4B7E-8221-34F3F15E5761Q38985262-2E79C09C-34C6-4E80-A2F8-700DFFF0BB0EQ39002543-1FE5DF4D-1F29-44B9-B221-9A5AE76CDF66Q42571627-1E19B8BC-A5B1-4E37-81E3-51922531EFA3Q42867339-36D7FCBE-0975-4A3B-B0EB-7F4440897859Q42969291-E047243D-4BA6-4509-88AF-812A5B5088FFQ43025486-2352BABB-ED71-4353-8202-D03F199B271D
P2860
Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@en
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@nl
type
label
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@en
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@nl
prefLabel
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@en
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@nl
P2093
P2860
P356
P1433
P1476
Tumor antigen specific iTreg a ...... press therapeutic vaccination.
@en
P2093
Dietlinde Wolf
Eckhard Podack
Maria Bodero
Taylor H Schreiber
P2860
P304
P356
10.4161/ONCI.20298
P577
2012-08-01T00:00:00Z